First Line Therapy In Advanced Hcc

Summary

Catherine T. Frenette, MD, and Darren S. Sigal, MD, talk about the Manon Allaire, MD, Greater Paris University Hospitals, Paris, France, comments on the current challenges in identifying patients ... Anthony B. El-Khoueiry, MD, Keck School of Medicine of USC, Los Angeles, CA, discusses highlights from the American Society ... Mark Yarchoan, MD, Johns Hopkins University, Baltimore, MD, discusses the evolving landscape of Prof Richard S Finn speaks to ecancer about the primary results from the phase 3 LEAP-002 study evaluating the efficacy and ... This video is part of the HMP Education content archive and may include previously accredited educational material. While this ... A Division of Liver Medicine Grand Rounds presented by Ben L. Da, MD, Hepatology Fellow. In this podcast episode from Clinical Care Options (CCO), Josep M. Llovet, MD, PhD, and Markus Peck-Radosavljevic, MD, MBA, ... In this video expert, Dr Timon Vandamme, discusses reviewing the outcomes in Lorenza Rimassa, MD, Hunimed University, Milan, Italy, discusses the current state of immunotherapy combinations for the ... Richard D. Kim, MD, Moffitt Cancer Center, Tampa, FL, presents the results of an ongoing Phase Ib study of regorafenib 80 ... Changhoon Yoo, MD, PhD, Asan Medical Center, Seoul, Republic of Korea outlines the Phase II RENOBATE (NCT04310709) ... Julien Edeline, MD, PhD, Centre Eugene Marquis, Rennes, France, discusses real-world data from the CHIEF cohort, which ... ... bevacizumab with tremelimumab and durvalumab (STRIDE) as